Role of endogenous nitric oxide in the control of exocrine and endocrine pancreatic secretion.
L-Arginine (L-Arg), that is a substrate for nitric oxide (NO) synthase, stimulates the release of pancreatic islet hormones but the mechanism of this stimulation is unknown. The aim of this study was to determine the role of NO in the control of endocrine and exocrine pancreatic secretion in response to sham feeding (SF), ordinary meat feeding (F), duodenal perfusion with nutrients and i.v. infusion of gastrin releasing peptide (GRP) or urecholine in conscious dogs with chronic pancreatic fistulas. SF1 F, duodenal nutrient and GRP and urecholine resulted in the stimulation of pancreatic secretion reaching, respectively, 50%, 50%, 40%, 85% and 20% of maximal response to caerulein (200 pmol/kg-h i.v.). Infusion of L-Arg (50 mg/kg + 5 mg/kg-h i.v.) almost doubled the basal pancreatic protein secretion and significantly increased the secretory response to SF, F, and duodenal nutrient. After i.v. administration of L-NNA (2.5 mg/kg + 0.5 mg/kg-h), an inhibitor of NO synthase, the pancreatic secretory responses to SF, F, duodenal nutrient, GRP and urecholine were significantly inhibited by about 74%, 70%, 70%, 80% and 30%, respectively. When L-Arg was combined with L-NNA, the reduction in pancreatic secretion induced by L-NNA was significantly attenuated. SF resulted in a marked rise in plasma insulin and glucagon and this response was completely abolished by L-NNA infusion. Insulin and glucagon levels were 2-3 folds increased by F and L-NNA infusion inhibited these responses while the addition of L-Arg partly reversed this inhibition. Duodenal nutrient produced several fold increase in plasma insulin and glucagon levels that were significantly reduced by L-NNA and this reduction was partially reversed by L-Arg. GRP also caused moderate rise in plasma insulin and glucagon levels which were significantly reduced by L-NNA and this was partially restored by L-Arg. We conclude that SF, F, duodenal nutrient, GRP or urecholine stimulate both the exocrine and endocrine pancreatic secretion and that these effects are mediated, at least in part, through the NO pathway.
Bilski
J
J
Institute of Physiology, Jagiellonian University School of Medicine, Cracow, Poland.
Konturek
S J
SJ
Bielański
W
W
D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D001626:Bethanechol Compounds / Q000494:pharmacology; D003864:Depression, Chemical; D004285:Dogs; D004435:Eating / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005934:Glucagon / Q000097:blood; D007328:Insulin / Q000097:blood; D007515:Islets of Langerhans / Q000294:innervation / Q000378:metabolism / Q000502:physiology*; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D019335:Nitroarginine; D010179:Pancreas / Q000294:innervation / Q000378:metabolism / Q000502:physiology*; D010187:Pancreatic Hormones / Q000494:pharmacology; D010275:Parasympathetic Nervous System / Q000502:physiology; D011506:Proteins / Q000378:metabolism; D014630:Vagus Nerve / Q000502:physiology
D001626:Bethanechol Compounds; D004791:Enzyme Inhibitors; D007328:Insulin; D010187:Pancreatic Hormones; D011506:Proteins; D019335:Nitroarginine; D009569:Nitric Oxide; D005934:Glucagon; D001120:Arginine; D019001:Nitric Oxide Synthase